News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

superDimension, Inc. Release: First Device to Enable Minimally-Invasive Access to Distant Areas of the Lungs Reaches FDA Milestone



9/5/2007 10:16:57 AM

MINNEAPOLIS--(BUSINESS WIRE)--The first device to allow physicians to access smaller, harder-to-reach lung lesions has received 510(k) clearance from the Food and Drug Administration (FDA). The inReachTM System, developed by Minneapolis-based superDimension (www.superdimension.com), provides electromagnetic navigation and guidance to distant regions of the lungs in a minimally-invasive manner, enabling doctors to diagnose lung cancer at earlier stages and potentially provide treatment sooner. The company recently raised nearly $21 million in venture capital to expand its sales, marketing and operations.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES